Saxaron-5 Tablet
Saxagliptin 5 mg
| Composition | Saxagliptin 5 mg |
|---|---|
| Dosage Form | Tablet |
| Pack Type | Box |
| Pack Size | 10 x 14 (Alu-Alu) |
| MRP | ₹ 4500 |
| Therapy | Cardiac + Diabetic — DPP-4 inhibitor (gliptin) |
| Storage | Store below 25°C. |
📱 WhatsApp Enquiry📞 Call: +919041677932
About Saxaron-5 Tablet
Saxaron-5 Tablet contains Saxagliptin 5 mg. Saxagliptin is a selective oral DPP-4 inhibitor that prolongs the action of incretin hormones (GLP-1, GIP), improving glucose-dependent insulin secretion.
Indicated for type-2 diabetes mellitus as monotherapy or in combination with metformin, sulphonylureas, thiazolidinediones or insulin.
Camrut Healthcare manufactures the Saxaron range under WHO-GMP conditions for PCD pharma franchise across India.
Indications
- Type-2 diabetes mellitus
- Add-on to metformin
- Combination with insulin
- Glycaemic control in CKD (dose-adjusted)
Mechanism of Action
Saxagliptin selectively inhibits DPP-4, preventing breakdown of GLP-1 and GIP. Elevated incretin levels increase glucose-dependent insulin secretion and suppress glucagon, improving glycaemic control without producing hypoglycaemia in non-eugenic states.
Dosage & Administration
['Adults: 1 tablet once daily, with or without food', 'Reduce to 2.5 mg in moderate-severe renal impairment', 'Use under physician supervision']
Side Effects
['Nasopharyngitis', 'Headache', 'Hypoglycaemia (when combined with SU/insulin)', 'Pancreatitis (rare)', 'Joint pain (rare)', 'Heart failure hospitalisation (SAVOR-TIMI 53)']
Contraindications & Precautions
['Type-1 diabetes', 'Diabetic ketoacidosis', 'History of severe pancreatitis', 'Significant heart failure history (relative)', 'Pregnancy']
Storage
Store below 25°C.
Saxaron-5 Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Frequently Asked Questions
q
a
q
a
q
a
q
a
q
a
Related Products